These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 18393877)
21. Therapeutic options in atrial flutter and fibrillation. Wilber DJ; Gunnar RM Hosp Pract (1995); 1997 May; 32(5):143-4, 149-50, 153-9 passim. PubMed ID: 9153143 [TBL] [Abstract][Full Text] [Related]
22. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Mitchell LB; Can J Cardiol; 2011; 27(1):91-7. PubMed ID: 21329866 [TBL] [Abstract][Full Text] [Related]
23. The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide. Obel OA; Camm AJ Drugs Aging; 1998 Jun; 12(6):461-76. PubMed ID: 9638394 [TBL] [Abstract][Full Text] [Related]
24. Predictors of failure of transoesophageal cardioversion of common atrial flutter. Vincenti A; Ciro A; De Ceglia S; Valsecchi MG; De Lorenzo P Europace; 2001 Jan; 3(1):10-5. PubMed ID: 11271944 [TBL] [Abstract][Full Text] [Related]
25. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review. Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151 [TBL] [Abstract][Full Text] [Related]
26. Atrial flutter: a focus on treatment options for a common supraventricular tachyarrhythmia. Andrew P; Montenero AS J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):558-67. PubMed ID: 17667025 [TBL] [Abstract][Full Text] [Related]
27. Dofetilide: a review of its use in atrial fibrillation and atrial flutter. McClellan KJ; Markham A Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390 [TBL] [Abstract][Full Text] [Related]
33. Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter. Crijns HJ; van Gelder IC; Lie KI Eur Heart J; 1994 Apr; 15 Suppl A():17-21. PubMed ID: 8070491 [TBL] [Abstract][Full Text] [Related]
34. Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical Cardioversion. Colangelo T; Johnson D; Ho R Tex Heart Inst J; 2021 Jun; 48(2):. PubMed ID: 34086956 [TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation. Nair M; George LK; Koshy SK J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348 [TBL] [Abstract][Full Text] [Related]
36. Hybrid therapy of atrial fibrillation. Santini M; Pignalberi C; Ricci R; Calò L Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [TBL] [Abstract][Full Text] [Related]
37. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Kerber RE Am J Cardiol; 1996 Oct; 78(8A):22-6. PubMed ID: 8903272 [TBL] [Abstract][Full Text] [Related]
38. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Zarkin GA; Bala MV; Calingaert B; VanderLugt JT Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487 [TBL] [Abstract][Full Text] [Related]
39. Treatment of atrial flutter. Chen JP South Med J; 2009 Sep; 102(9):879. PubMed ID: 19668052 [No Abstract] [Full Text] [Related]